Pulmatrix Inc. Stock
Pulmatrix Inc. Stock
A loss of -2.330% shows a downward development for Pulmatrix Inc..
The community is currently still undecided about Pulmatrix Inc. with 1 Buy predictions and 1 Sell predictions.
Based on the current price of 1.68 € the target price of 9 € shows a potential of 435.71% for Pulmatrix Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Pulmatrix Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Pulmatrix Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Pulmatrix Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Pulmatrix Inc. | -2.330% | -5.085% | 3.704% | -34.118% | 2.564% | -88.933% | -91.642% |
Ardelyx Inc. | 28.120% | 34.723% | 16.633% | 93.717% | 39.758% | 44.250% | - |
Evolus Inc | 4.240% | 17.143% | 2.500% | 61.842% | 35.912% | 68.493% | - |
Salarius Pharmaceuticals Inc. | -1.300% | 6.573% | 5.581% | -68.472% | -18.198% | -98.220% | -99.993% |
Comments
Pulmatrix, Inc. (NASDAQ: PULM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Show more
Ratings data for PULM provided by MarketBeat